文献速递糖尿病

1型糖尿病长期并发症累积发病率之间的关系:DCCT/EDIC研究

Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study.
PubMed 文献 · Diabetes Care · 2023-01-01

该研究在DCCT/EDIC队列中评估1型糖尿病患者约30年间增殖性糖尿病视网膜病变、临床有意义黄斑水肿、估算肾小球滤过率下降、截肢、心血管疾病和死亡的累积发病率及其关联。结果显示各并发症累积发病率从3%(截肢)到37%(临床有意义黄斑水肿)不等,多种并发症之间风险显著升高,且校正年龄、糖尿病病程和平均更新HbA1c后关联仍存在。

要点

  • 并发症累积发病率从3%(截肢)到37%(临床有意义黄斑水肿)不等。
  • 有临床有意义黄斑水肿者增殖性糖尿病视网膜病变累积发病率为66%,无者为15%。
  • 校正年龄、病程和HbA1c后,多种微血管和大血管并发症及死亡风险仍显著相关。

核心结论

  • 长期微血管和大血管并发症及死亡高度相关,年龄、糖尿病病程和血糖水平不能完全解释这些关联。

研究设计与样本

  • 在糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究(DCCT/EDIC)中,对1型糖尿病患者约30年间的增殖性糖尿病视网膜病变、临床有意义黄斑水肿、估算肾小球滤过率下降、截肢、心血管疾病和死亡进行评估。

主要发现

  • 并发症累积发病率从3%(截肢)到37%(临床有意义黄斑水肿)不等。
  • 有临床有意义黄斑水肿者增殖性糖尿病视网膜病变累积发病率为66%,无者为15%;有估算肾小球滤过率下降者增殖性糖尿病视网膜病变累积发病率为59%,无者为29%;有截肢者增殖性糖尿病视网膜病变累积发病率为68%,无者为32%。
  • 有增殖性糖尿病视网膜病变者估算肾小球滤过率下降累积发病率为25%,无者为9%;有截肢者估算肾小球滤过率下降累积发病率为48%,无者为13%;有心血管疾病者估算肾小球滤过率下降累积发病率为30%,无者为11%。
  • 有估算肾小球滤过率下降者心血管疾病累积发病率为37%,无者为14%;有截肢者心血管疾病累积发病率为50%,无者为16%。
  • 有估算肾小球滤过率下降者死亡累积发病率为22%,无者为9%;有截肢者死亡累积发病率为35%,无者为8%;有心血管疾病者死亡累积发病率为25%,无者为8%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the relationships between the cumulative incidences of long-term complications in individuals with type 1 diabetes (T1D) and assess whether observed associations are independent of age, duration of diabetes, and glycemic levels. METHODS: Proliferative diabetic retinopathy (PDR), clinically significant macular edema (CSME), reduced estimated glomerular filtration rate (eGFR), amputations, cardiovascular disease (CVD), and mortality were assessed in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study over ∼30 years. RESEARCH DESIGN AND RESULTS: The cumulative incidence of complications ranged from 3% (amputations) to 37% (CSME). There were large differences in the cumulative incidence of PDR between participants with versus without prior CSME (66% vs. 15%), reduced eGFR (59% vs. 29%), and amputation (68% vs. 32%); reduced eGFR with or without prior PDR (25% vs. 9%), amputation (48% vs. 13%), and CVD (30% vs. 11%); CVD with or without prior reduced eGFR (37% vs. 14%) and amputation (50% vs. 16%); and mortality with or without prior reduced eGFR (22% vs. 9%), amputation (35% vs. 8%), and CVD (25% vs. 8%). Adjusted for age, duration of T1D, and mean updated HbA1c, the complications and associations with higher risk included PDR with CSME (hazard ratio [HR] 1.88; 95% CI 1.42, 2.50), reduced eGFR (HR 1.41; 95% CI 1.01, 1.97), and CVD (HR 1.43; 95% CI 1.06, 1.92); CSME with higher risk of PDR (HR 3.94; 95% CI 3.18 4.89), reduced eGFR (HR 1.49; 95% CI 1.10, 2.01), and CVD (HR 1.35; 95% CI 1.03, 1.78); reduced eGFR with higher risk of CVD (HR 2.09; 95% CI 1.44, 3.03), and death (HR 3.40; 95% CI 2.35, 4.92); amputation(s) with death (HR 2.97; 95% CI 1.70, 2.90); and CVD with reduced eGFR (HR 1.59; 95% CI 1.08, 2.34) and death (HR 1.95; 95% CI 1.32, 2.90). CONCLUSIONS: Long-term micro- and macrovascular complications and mortality are highly correlated. Age, diabetes duration, and glycemic levels do not completely explain these associations.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bebu I, Braffett BH, de Boer IH, et al. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2023. PMID: 36520643. doi:10.2337/dc22-1744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。